📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Roivant

1.1 - Company Overview

Roivant Logo

Roivant

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of biopharmaceutical medicines and healthcare technologies, developing VTAMA (tapinarof) cream for plaque psoriasis and atopic dermatitis in adults and children 2+, Brepocitinib (TYK2/JAK1) for dermatomyositis and non-infectious uveitis, IMVT-1402 (FcRn inhibitor) for autoimmune diseases including Graves' disease, Namilumab for sarcoidosis, and Mosliciguat for pulmonary hypertension associated with interstitial lung disease.

Products and services

  • VTAMA (Tapinarof) Cream: A topical therapy engineered for plaque psoriasis and atopic dermatitis, usable by adults and children as young as 2 years
  • IMVT-1402: An FcRn inhibitor developed for autoimmune diseases such as Graves' disease, engineered to reduce circulating IgG levels
  • Brepocitinib: A small-molecule drug targeting TYK2/JAK1, under development for treating dermatomyositis and non-infectious uveitis in patients

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Roivant

Questcor Pharmaceuticals Logo

Questcor Pharmaceuticals

HQ: United States Website
  • Description: Provider of biopharmaceutical treatments for serious, difficult-to-treat autoimmune and inflammatory disorders, focused on neurology and nephrology, and supporting research efforts in a variety of conditions.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Questcor Pharmaceuticals company profile →
Aurex Labs Logo

Aurex Labs

HQ: United States Website
  • Description: Provider of fully integrated pharmaceutical development and manufacturing services, including high-quality clinical supplies, tablets, and soft gelatin capsules. Maintains capabilities for manufacturing various dosage forms and quality control.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Aurex Labs company profile →
Gilead Logo

Gilead

HQ: United States Website
  • Description: Provider of biopharmaceutical therapies for critical diseases, discovering, developing, manufacturing and commercializing treatments across virology, oncology and inflammation. Portfolio includes Biktarvy and Descovy for HIV-1 (treatment and PrEP) and Epclusa for HCV, with efforts to transform viral diseases into manageable conditions and expand access to care.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Gilead company profile →
New Haven Pharmaceuticals Logo

New Haven Pharmaceuticals

HQ: United States Website
  • Description: Provider of prescription pharmaceuticals utilizing drugs or GRAS active pharmaceutical ingredients.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full New Haven Pharmaceuticals company profile →
Immunex Logo

Immunex

HQ: United States Website
  • Description: Provider of therapeutic products for cancer, infectious diseases, and autoimmune disorders. Develops, manufactures, and markets treatments including Enbrel for rheumatoid arthritis and Novantrone for acute nonlymphocytic leukemia and pain associated with prostate cancer.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Immunex company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Roivant

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Roivant

2.2 - Growth funds investing in similar companies to Roivant

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Roivant

4.2 - Public trading comparable groups for Roivant

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Roivant

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Roivant

What does Roivant do?

Roivant is a provider of biopharmaceutical medicines and healthcare technologies, developing VTAMA (tapinarof) cream for plaque psoriasis and atopic dermatitis in adults and children 2+, Brepocitinib (TYK2/JAK1) for dermatomyositis and non-infectious uveitis, IMVT-1402 (FcRn inhibitor) for autoimmune diseases including Graves' disease, Namilumab for sarcoidosis, and Mosliciguat for pulmonary hypertension associated with interstitial lung disease.

Who are Roivant's competitors?

Roivant's competitors and similar companies include Questcor Pharmaceuticals, Aurex Labs, Gilead, New Haven Pharmaceuticals, and Immunex.

Where is Roivant headquartered?

Roivant is headquartered in United States.

How many employees does Roivant have?

Roivant has 1,000 employees 🔒.

When was Roivant founded?

Roivant was founded in 2010 🔒.

What sector and industry vertical is Roivant in?

Roivant is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Roivant

Who are the top strategic acquirers in Roivant's sector and industry

Top strategic M&A buyers and acquirers in Roivant's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Roivant?

Top strategic M&A buyers groups and sectors for Roivant include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Roivant's sector and industry vertical

Which are the top PE firms investing in Roivant's sector and industry vertical?

Top PE firms investing in Roivant's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Roivant's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Roivant's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Roivant's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Roivant include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Roivant's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Roivant?

The key public trading comparables and valuation benchmarks for Roivant include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Roivant for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Roivant with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Roivant's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Roivant with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Roivant's' sector and industry vertical?

Access recent funding rounds and capital raises in Roivant's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Roivant

Launch login modal Launch register modal